xHaMMaDy/AD-scRNA2QSAR

A comprehensive computational pipeline that bridges single-cell genomics and cheminformatics to accelerate Alzheimer's Disease research. This project integrates advanced bioinformatics and machine learning to create a seamless workflow from raw single-cell RNA sequencing data to predictive drug discovery models.

36
/ 100
Emerging

This project helps Alzheimer's Disease researchers analyze single-cell RNA sequencing data and predict potential drug candidates. It takes raw single-cell RNA sequencing data and chemical compound information (SMILES strings) as input. It then outputs detailed cell type annotations, cell communication networks, and predictions of a compound's bioactivity against AD-related targets. Neurodegenerative disease researchers, especially those in drug discovery, would find this useful for accelerating their work.

No commits in the last 6 months.

Use this if you are an Alzheimer's Disease researcher needing to go from raw single-cell genomics data to predictive drug discovery models efficiently, without extensive coding.

Not ideal if your research is outside of Alzheimer's Disease or you require highly customized, domain-specific machine learning models beyond bioactivity prediction.

Alzheimer's Disease research neurodegenerative diseases single-cell genomics cheminformatics drug discovery
Stale 6m No Package No Dependents
Maintenance 2 / 25
Adoption 5 / 25
Maturity 15 / 25
Community 14 / 25

How are scores calculated?

Stars

12

Forks

3

Language

Jupyter Notebook

License

MIT

Last pushed

Jul 13, 2025

Commits (30d)

0

Get this data via API

curl "https://pt-edge.onrender.com/api/v1/quality/ml-frameworks/xHaMMaDy/AD-scRNA2QSAR"

Open to everyone — 100 requests/day, no key needed. Get a free key for 1,000/day.